MON-150, a versatile monoclonal antibody against involucrin: characterization and applications
- PMID: 1503502
- DOI: 10.1007/BF00372711
MON-150, a versatile monoclonal antibody against involucrin: characterization and applications
Abstract
A monoclonal antibody, designated MON-150, was found serendipitously to react strongly with the granular layer of normal human epidermis and with the upper spinous layers of psoriatic epidermis. From analysis by flow cytometry of cultured human keratinocytes, it appeared that the percentage of MON-150-positive cells strongly increased when the cells reached confluence and the growth fraction declined. To identify the antigen recognized by MON-150, a lysate of human keratinocytes was subjected to affinity chromatography using a MON-150 Sepharose column. This yielded a single protein of approximately 350 kDa as measured on Superose 6 FPLC gel permeation chromatography using non-denaturing conditions. In Western blot analysis under denaturing and reducing conditions, a 140-kDa protein was detected. The subcellular localization and the molecular weight of the antigen recognized by MON-150 suggested that the antigen involved might be involucrin. This was confirmed using a commercial polyclonal antiserum against involucrin. We conclude that MON-150 is a new, versatile antibody against human involucrin.
Similar articles
-
Reactivity of monoclonal anti-human skin basal cell antibody to cultured keratinocytes in serum-free medium.J Dermatol Sci. 1990 Jan;1(1):47-55. doi: 10.1016/0923-1811(90)90009-3. J Dermatol Sci. 1990. PMID: 2078541
-
Abnormal distribution of epidermal protein antigens in psoriatic epidermis.J Dermatol. 1991 Mar;18(3):143-51. doi: 10.1111/j.1346-8138.1991.tb03057.x. J Dermatol. 1991. PMID: 1715894
-
Characterization of monoclonal antibodies generated to the cornified envelope of human cultured keratinocytes.J Invest Dermatol. 1987 Nov;89(5):454-9. doi: 10.1111/1523-1747.ep12460759. J Invest Dermatol. 1987. PMID: 3668290
-
Abnormal maturation pathway of keratinocytes in psoriatic skin.Br J Dermatol. 1985 Jun;112(6):647-53. doi: 10.1111/j.1365-2133.1985.tb02332.x. Br J Dermatol. 1985. PMID: 3890921
-
Involucrin and other markers of keratinocyte terminal differentiation.J Invest Dermatol. 1983 Jul;81(1 Suppl):100s-3s. doi: 10.1111/1523-1747.ep12540786. J Invest Dermatol. 1983. PMID: 6345687 Review.
Cited by
-
The immunohistochemical effects of a single challenge with an intermediate dose of ultraviolet B on normal human skin.Arch Dermatol Res. 1996 Aug;288(9):510-6. doi: 10.1007/BF02505246. Arch Dermatol Res. 1996. PMID: 8874744
-
Immortalized N/TERT keratinocytes as an alternative cell source in 3D human epidermal models.Sci Rep. 2017 Sep 19;7(1):11838. doi: 10.1038/s41598-017-12041-y. Sci Rep. 2017. PMID: 28928444 Free PMC article.
-
Changes in keratinocyte differentiation following mild irritation by sodium dodecyl sulphate.Arch Dermatol Res. 1996 Oct;288(11):684-90. doi: 10.1007/BF02505278. Arch Dermatol Res. 1996. PMID: 8931871
-
Epidermal differentiation characteristics of the psoriatic plaque during treatment with calcipotriol.Arch Dermatol Res. 1996 Jun;288(7):366-72. doi: 10.1007/BF02507105. Arch Dermatol Res. 1996. PMID: 8818184 Clinical Trial.
-
Novel methodologies for host-microbe interactions and microbiome-targeted therapeutics in 3D organotypic skin models.Microbiome. 2023 Oct 17;11(1):227. doi: 10.1186/s40168-023-01668-x. Microbiome. 2023. PMID: 37849006 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials